Association of Chronic Obstructive Pulmonary Disease with Morbidity and Mortality in Patients with Peripheral Artery Disease: Insights from the EUCLID Trial

Autor: Galani J, Mulder H, Rockhold FW, Weissler EH, Baumgartner I, Berger JS, Blomster JI, Fowkes FGR, Hiatt WR, Katona BG, Norgren L, Mahaffey KW, Quint JK, Patel MR, Jones WS

Publikováno v: International Journal of COPD, Vol Volume 16, Pp 841-851 (2021)

Jemi Galani,1 Hillary Mulder,2 Frank W Rockhold,2 E Hope Weissler,2,3 Iris Baumgartner,4 Jeffrey S Berger,5 Juuso I Blomster,6 F Gerry R Fowkes,7 William R Hiatt,8,9 Brian G Katona,10 Lars Norgren,11 Kenneth W Mahaffey,12 Jennifer K Quint,13 Manesh R

Externí odkaz: https://doaj.org/article/3fca998d9030415bb4b98bb35420f4ff

Rivaroxaban Plus Aspirin for Extended Thromboprophylaxis in Acutely Ill Medical Patients: Insights from the MARINER Trial.

Autor: Spyropoulos AC; The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, The Feinstein Institute for Medical Research, New York, New York, United States.; Department of Medicine, Anticoagulation and Clinical Thrombosis Services, Northwell Health at Lenox Hill Hospital, New York, New York, United States., Goldin M; Northwell Health, Great Neck, New York, United States., Ageno W; Department of Medicine and Surgery, University of Insubria, Varese, Italy.; University of Insubria, Varese, Italy., Albers GW; Stanford Stroke Center, Stanford Medical Center, Stanford University, Palo Alto, California, United States., Elliott CG; Department of Medicine, University of Utah and Intermountain Healthcare, Salt Lake City, Utah, United States., Hiatt WR; Division of Cardiology, University of Colorado School of Medicine.; CPC Clinical Research, Aurora, Colorado, United States., Halperin JL; Cardiovascular Institute, Mount Sinai Medical Center, New York, New York, United States., Maynard G; University of California at Davis, Sacramento, California, United States., Steg PG; Université de Paris, Assistance Publique-Hôpitaux de Paris, and INSERM U-1148, Paris, France., Weitz JI; McMaster University.; The Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada., Spiro TE; Bayer US, LLC, Whippany, New Jersey, United States., Lu W; Cardiovascular Clinical Development, Janssen Research and Development, LLC, Raritan, New Jersey, United States., Marsigliano J; Cardiovascular Clinical Development, Janssen Research and Development, LLC, Raritan, New Jersey, United States., Raskob GE; Hudson College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States., Barnathan ES; Cardiovascular Clinical Development, Janssen Research and Development, LLC, Raritan, New Jersey, United States.

Publikováno v: TH open : companion journal to thrombosis and haemostasis [TH Open] 2022 Jul 11; Vol. 6 (3), pp. e177-e183. Date of Electronic Publication: 2022 Jul 11 (Print Publication: 2022).

World regional differences in outcomes for patients with peripheral artery disease: Insights from the EUCLID trial.

Autor: Norgren L; Faculty of Medicine and Health, Örebro University, Örebro, Sweden., North R; Department of Statistics, North Carolina State University, Raleigh, NC, USA., Baumgartner I; Division of Angiology, Swiss Cardiovascular Centre, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Berger JS; Departments of Medicine and Department of Surgery, New York University School of Medicine, New York, NY, USA., Blomster JI; Turku University Hospital, University of Turku, Turku, Finland., Hiatt WR; Division of Cardiology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA., Jones WS; Duke Clinical Research Institute, Durham, NC, USA.; Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA., Katona BG; AstraZeneca Gaithersburg, Gaithersburg, MD, USA., Mahaffey KW; Stanford Center for Clinical Research, Stanford University School of Medicine, Stanford, CA, USA., Mulder H; Duke Clinical Research Institute, Durham, NC, USA., Patel MR; Duke Clinical Research Institute, Durham, NC, USA.; Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA., Rockhold FW; Duke Clinical Research Institute, Durham, NC, USA., Fowkes FGR; Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK.

Publikováno v: Vascular medicine (London, England) [Vasc Med] 2022 Feb; Vol. 27 (1), pp. 21-29. Date of Electronic Publication: 2021 Sep 13.

Treatment-Dose LMWH versus Prophylactic/Intermediate Dose Heparins in High-Risk COVID-19 Inpatients: Rationale and Design of the HEP-COVID Trial.

Autor: Goldin M; Institute of Health Innovations and Outcomes Research, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, United States.; Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, United States., Giannis D; Institute of Health Innovations and Outcomes Research, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, United States., Diab W; Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, United States., Wang J; Institute of Health Innovations and Outcomes Research, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, United States.; Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, United States., Khanijo S; Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, United States., Sharifova G; Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, United States., Cohen M; Department of Medicine, Newark Beth Israel Medical Center, Newark, New Jersey, United States., Lund JM; Wellspan York Hospital, York, Pennsylvania, United States., Mignatti A; Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, United States.; Department of Cardiology, Lenox Hill Hospital, Northwell Health, New York, New York, United States., Gianos E; Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, United States.; Department of Cardiology, Lenox Hill Hospital, Northwell Health, New York, New York, United States., Tafur A; Department of Medicine and Vascular Medicine, NorthShore University Health System, Evanston, Illinois, United States.; Division of Cardiology, University of Chicago, Pritzker School of Medicine, Chicago, Illinois, United States., Lewis PA; Evidence Based Medicine, Baycare Health System, Clearwater, Florida, United States., Cohoon K; Division of Cardiovascular Medicine, Department of Medicine, Froedtert and Medical College of Wisconsin, Milwaukee, Wisconsin, United States., Kittelson JM; Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States., Lesser ML; Institute of Health Innovations and Outcomes Research, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, United States.; Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, United States., Sison CP; Institute of Health Innovations and Outcomes Research, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, United States.; Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, United States., Rahman H; Institute of Health Innovations and Outcomes Research, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, United States., Ochani K; Institute of Health Innovations and Outcomes Research, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, United States., Hiatt WR; Biostatistics, Colorado Prevention Center (CPC) Clinical Research, Aurora, Colorado, United States.; Division of Cardiology, University of Colorado, School of Medicine, Aurora, Colorado, United States., Dale RA; Biostatistics, Colorado Prevention Center (CPC) Clinical Research, Aurora, Colorado, United States., Anderson VE; Biostatistics, Colorado Prevention Center (CPC) Clinical Research, Aurora, Colorado, United States., Bonaca M; Biostatistics, Colorado Prevention Center (CPC) Clinical Research, Aurora, Colorado, United States.; Division of Cardiology, University of Colorado, School of Medicine, Aurora, Colorado, United States., Halperin JL; Department of Cardiovascular Medicine, The Cardiovascular Institute, Mount Sinai Medical Center, New York, New York, United States., Weitz JI; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada.; Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada., Spyropoulos AC; Institute of Health Innovations and Outcomes Research, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, United States.; Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, United States.

Publikováno v: Thrombosis and haemostasis [Thromb Haemost] 2021 Dec; Vol. 121 (12), pp. 1684-1695. Date of Electronic Publication: 2021 May 28.

Safety and Effectiveness of Paclitaxel Drug-Coated Devices in Peripheral Artery Revascularization: Insights From VOYAGER PAD.

Autor: Hess CN; Department of Medicine, Division of Cardiology, University of Colorado School of Medicine, Aurora, Colorado, USA; CPC Clinical Research, Aurora, Colorado, USA. Electronic address: connie.hess@cuanschutz.edu., Patel MR; Duke Clinical Research Institute, Division of Cardiology, Duke University, Durham, North Carolina, USA., Bauersachs RM; Department of Vascular Medicine, Klinikum Darmstadt, Darmstadt, and Center for Thrombosis and Hemostasis, University of Mainz, Mainz, Germany., Anand SS; Population Health Research Institute, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada., Debus ES; Department of Vascular Medicine, Vascular Surgery-Angiology-Endovascular Therapy, University of Hamburg-Eppendorf, Hamburg, Germany., Nehler MR; CPC Clinical Research, Aurora, Colorado, USA; Department of Surgery, Division of Vascular Surgery, University of Colorado School of Medicine, Aurora, Colorado, USA., Fanelli F; Vascular and Interventional Radiology Department, Careggi University Hospital, University of Florence, Florence, Italy., Yeh RW; Smith Center for Outcomes Research in Cardiology, Department of Medicine, Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Secemsky EA; Smith Center for Outcomes Research in Cardiology, Department of Medicine, Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Beckman JA; Department of Medicine, Division of Cardiology, Vanderbilt University, Nashville, Tennessee, USA., Mauri L; Medtronic, Inc, Minneapolis, Minnesota, USA., Govsyeyev N; CPC Clinical Research, Aurora, Colorado, USA; Department of Surgery, Division of Vascular Surgery, University of Colorado School of Medicine, Aurora, Colorado, USA., Capell WH; CPC Clinical Research, Aurora, Colorado, USA; Department of Medicine, Division of Endocrinology, University of Colorado School of Medicine, Aurora, Colorado, USA., Brackin T; CPC Clinical Research, Aurora, Colorado, USA., Berkowitz SD; Thrombosis Group Head, Clinical Development, Bayer U.S., Whippany, New Jersey, USA., Muehlhofer E; Bayer, Wuppertal, Germany., Haskell LP; Janssen Research and Development, Raritan, New Jersey, USA., Hiatt WR; Department of Medicine, Division of Cardiology, University of Colorado School of Medicine, Aurora, Colorado, USA; CPC Clinical Research, Aurora, Colorado, USA., Bonaca MP; Department of Medicine, Division of Cardiology, University of Colorado School of Medicine, Aurora, Colorado, USA; CPC Clinical Research, Aurora, Colorado, USA.

Publikováno v: Journal of the American College of Cardiology [J Am Coll Cardiol] 2021 Nov 02; Vol. 78 (18), pp. 1768-1778.